BioElectronics Announces the Launch of the ‘Try & Tell’ Program

FREDERICK, MD, Dec. 07, 2017 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device ActiPatch, announced today the launch of their “Try and Tell” program in the United States. The ActiPatch® Musculoskeletal Pain Therapy is a wearable medical device that is FDA cleared for non-prescription use. […]

Andy Whelan, President BioElectronics Updates Uptick Newswire “Stock Day” Listeners

Phoenix, AZ , Nov. 20, 2017 (GLOBE NEWSWIRE) — Uptick Newswire announces interview by host Everett Jolly of returning guest Andy Whelan President of BioElectronics Corp. (OTC: BIEL, the “Company”). Starting off the interview, Mr. Whelan presented an overview of the Company’s pain products, its domestic and international sales, and clinical trials status. The interview […]

BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives

FREDERICK, MD–(Marketwired – Nov 13, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. We are pleased to announce that PharmEvo, our distributor in Vietnam, is hosting an Electroceuticals symposium following a successful launch of their sales & marketing strategy. Additionally, PharmEvo is expanding their territory to cover […]

BioElectronics to Showcase Products at World’s Largest Medical Tradeshow

FREDERICK, MD–(Marketwired – Nov 9, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. The company announced today that it will showcase its range of pain and inflammation reduction products at MEDICA 2017 in Germany, dubbed as the leading international tradeshow for the medical industry. The company will […]

BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)

FREDERICK, MD–(Marketwired – Nov 6, 2017) – BioElectronics Corporation ( OTC PINK :BIEL ), the maker of advanced consumer pain management medical device, ActiPatch, today announced that it has taken on the responsibility to find a DRUG-FREE solution to the Opioid Crisis. The reach of the opioid crisis now stretches wide and far, claiming an American life every […]

BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain

FREDERICK, MD–(Marketwired – Oct 16, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating chronic musculoskeletal lower back pain. Low back pain is highly prevalent and affects 1 in 3 adult Americans, accounting for about $ 90 billion in direct spending every […]

BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD–(Marketwired – Sep 25, 2017) –  BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the […]

Letter from BioElectronics’ (OTC PINK: BIEL) President to Investors

FREDERICK, MD–(Marketwired – Aug 28, 2017) – The following is a statement from BioElectronics ( OTC PINK : BIEL ). Dear Fellow Shareholders, These are busy and exciting times at BioElectronics ( OTC PINK : BIEL ). New Product Opportunities Over the last few years, there have been two significant developments: 1) There has been a paradigm shift in the medical community’s understanding of how […]

BioElectronics’ President Discusses Company’s Many Opportunities

FREDERICK, MD–(Marketwired – Aug 22, 2017) – The following is a statement from BioElectronics ( OTC PINK : BIEL ). Dear Fellow Shareholders, These are busy and exciting times at BioElectronics. New Product Opportunities Over the last few years, there have been two significant developments: 1) There has been a paradigm shift in the medical community’s understanding of how […]

BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing

FREDERICK, MD–(Marketwired – Aug 22, 2017) –  BioElectronics Corporation ( OTC PINK : BIEL ), the maker of advanced consumer pain management medical devices, today announced that it has engaged Keith Nalepka as the Vice President of Sales and Marketing. Keith has over 15 years of experience working in the retail sales industry, both with large multi-million dollar brands […]